OnCall

Biosimilar Series: Part 5

September 21, 2022 AmerisourceBergen Episode 5
Biosimilar Series: Part 5
OnCall
More Info
OnCall
Biosimilar Series: Part 5
Sep 21, 2022 Episode 5
AmerisourceBergen

In this episode, the fifth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about operationalizing biosimilars into practice and the differences and similarities of this process for biosimilars versus their counterparts.

If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCallGPO@gmail.com

Show Notes

In this episode, the fifth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about operationalizing biosimilars into practice and the differences and similarities of this process for biosimilars versus their counterparts.

If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCallGPO@gmail.com